Healthy volunteers needed to test new fatty liver Drug's absorption
NCT ID NCT07334080
First seen Jan 12, 2026 · Last updated May 16, 2026 · Updated 18 times
Summary
This early-stage study enrolls 72 healthy adults to see if taking ECC4703 with food changes how the body absorbs it, and to compare four different pill versions. Participants receive a single dose and are monitored for safety and drug levels in the blood. The drug is being developed for a liver condition called MASH, but this trial does not treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CMAX Clinical Research Pty Ltd
RECRUITINGAdelaide, South Australia, 5000, Australia
Contact
Conditions
Explore the condition pages connected to this study.